SCHEMBL21499708

SCHEMBL21499708

CN1c2nc(-c3cccc(-c4ccccc4)c3)n(Cc3ccc(Cl)cn3)c2C(=O)N(CCCO)C1O

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ COMT P21964 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ TSHR P16473 2/20 0.32
▸ P2RX3 P56373 2/20 0.32
▸ PDE5A O76074 1/20 0.32
▸ PDE4A P27815 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4C Q08493 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ TRPC5 Q9UL62 3/20 0.32
▸ CCNC P24863 1/20 0.31
▸ CDK8 P49336 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ MCHR1 Q99705 1/20 0.30
▸ MDM2 Q00987 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19505043 0.94 TRPC5 (0.37) P2RX3TRPC5CCNCCDK8ALDH1A1
SCHEMBL18834622 0.90 P2RX3 (0.35) P2RX3TRPC5CCNCCDK8
SCHEMBL18835240 0.87 TRPC5 (0.47) P2RX3TRPC5
SCHEMBL18834470 0.86 TRPC5 (0.35) TSHRP2RX3PDE4DTRPC5ALDH1A1
SCHEMBL18834542 0.85 P2RX3 (0.31) TSHRP2RX3ALDH1A1MDM2
SCHEMBL21316348 0.80 ALDH1A1 (0.40) TSHRPDE5APDE4APDE4BPDE4C
SCHEMBL18834253 0.78 ADORA3 (0.46) TLR7TSHRPDE5APDE4APDE4B
SCHEMBL19375606 0.78 P2RX3 (0.37) P2RX3TRPC5
SCHEMBL18835291 0.76 COMT (0.34) COMTTLR7TSHRP2RX3TRPC5
SCHEMBL20432456 0.76 TRPC5 (0.43) TRPC5MAPTMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 COMT 1317/4885TLR7 3439/4885TSHR 4540/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 COMT 1317/4885TLR7 3439/4885TSHR 4540/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 COMT 1317/4885TLR7 3439/4885TSHR 4540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback